NON-STERILE DRUG COMPOUNDING: PROFESSIONAL PRATICE EVALUATION
PP-023
EVALUATION OF THE PERFORMANCE OF AN AUTOMATED SYSTEM FOR THE PREPARATION OF CYTOTOXIC BAGS
PP-022
EVALUATION OF LONG-TERM BIOLOGICAL ACTIVITY OF CETUXIMAB 5.0 mg/mL (ERBITUX) BY AN AD HOC ELISA METHOD
PP-021
READY-TO-USE MEDICINES SAFETY?! NATIONAL EVALUATION OF STANDARDIZED DRUG SOLUTIONS IN THE INTENSIVE CARE MEDICINE
PP-020
IMPROVING EFFICIENCY BY EXTENDING THE STABILITY OF BORTEZOMIB
PP-019
COMPATIBILITY OF IRINOTECAN-LOADED DC BEADS WITH DIFFERENT VOLUMES AND TYPES OF NON-IONIC CONTRAST MEDIA
PP-018
PREPARATION OF EYE DROPS FOR VERNAL KERATOCONJUNCTIVITIS: THE PHARMACIST ADDED TO A TEAM ACTS AS A FULCRUM BETWEEN DOCTOR AND PATIENT
PP-017
EVALUATION OF LONG-TERM BIOLOGICAL ACTIVITY OF BEVACIZUMAB 25 mg/mL BY AN AD HOC ELISA METHOD
PP-016
VALIDATION OF A NEW METHOD OF STERILITY TESTING FOR THE VITAMIN AND LIPID MIXTURES DESTINED FOR THE NEONATALOGY DEPARTMENT
PP-015
USING A CLOSED-SYSTEM TRANSFER DEVICE LEADS TO BETTER CONTROL OF OCCUPATIONAL EXPOSURE IN ROUTINE PRACTICE
PP-014
PHYSICAL AND CHEMICAL STABILITY OF SEVOFLURANE IN POLYPROPYLENE SYRINGES
PP-013
DESENSITIZATION PROTOCOL FOR PEMETREXED HYSENSITIVITY: A CASE REPORT
PP-012
ENVIRONMENTAL CONTAMINATION BY CYCLOPHOSPHAMIDE: COMPARISON OF MANUAL PRODUCTION IN BIOLOGICAL SAFETY CABINET AND ROBOT-ASSISTED PRODUCTION BY APOTECAchemo
PP-010
OPTIMIZATION IN THE USE OF DRUGS FOR AGE-RELATED MACULAR DEGENERATION
PP-009
THE IPILIMUMAB DRUG DAY: AN INSTRUMENT TO CONTAIN COSTS
